MYC and breast carcinoma: Zhang et al. [15] examined by ELISA multiplex system the presence of AAbs to seven TAAs, IMP1, p62, Koc, p53, c-MYC, cyclin B1, and survivin, in the sera of 527 cancer patients (64, breast carcinoma; 45, colorectal carcinoma; 91, gastric carcinoma; 65, hepatocellular carcinoma; 56, lung carcinoma; and 206, prostate carcinoma) and 346 normal subjects.